Clinical Trial Update: An Open Label Trial of Bupropion and Naltrexone for Binge Drinking [Phase 2]

View source ↗

Summary

A Phase 2 open-label trial assessed bupropion and naltrexone for binge drinking; results were posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Binge Drinking

Drugs mentioned

• bupropion and naltrexone

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Binge Drinking | Phase 2 | Status: COMPLETED | Results posted: 2018-12-26